High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study-Reference-Cited by-同舟云学术

High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study

Published:2006-03 Issue:2 Volume:17 Page:113-124
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Watala Cezary,Ulicna Olga,Golanski Jacek,Nocun Marek,Waczulíková Iveta,Markuszewski Leszek,Drzewoski Józef

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference54 articles.

1. Glycation and oxidation: a role in the pathogenesis of atherosclerosis;Lyons;Am J Cardiol,1993

2. The AGE-receptor in the pathogenesis of diabetic complications;Vlassara;Diabetes Metab Res Rev,2001

3. Nonenzymatic glucosylation of proteins: a new and rapid solution for in vitro investigation;Vaughan;FEBS Lett,1984

4. Collagen as a model system to investigate the use of aspirin as an inhibitor of protein glycation and crosslinking;Hadley;Micron,2001

5. Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo;Swamy;Invest Ophthalmol Vis Sci,1989

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Concentration of Cortisol Negatively Associates with Platelet Reactivity in Older Subjects;International Journal of Molecular Sciences;2022-12-31

2. Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y12 Antagonists in a cAMP- and Calcium-Dependent Manner;Pharmaceuticals;2020-07-31

3. Adenosine Receptor Agonists Exhibit Anti-Platelet Effects and the Potential to Overcome Resistance to P2Y12 Receptor Antagonists;Molecules;2019-12-28

4. Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy;International Journal of Molecular Sciences;2019-11-03

5. Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y12 antagonists;Vascular Pharmacology;2019-02